OpenVSafe by OpenVAERS
Search V-safe

LCN-21234-67569

2 vaccinations 2 coded responses 22 check-ins 2 free-text entries 0 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
601 / IL
Registered
2022-02-10
Relationship
Child or adolescent in my care
Guardian
F68-17786-22655
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-02-10
    Registered in v-safe
  2. 2022-02-10
    Dose 1 — Pfizer-BioNTech
  3. 2022-02-10
    Survey response — day 0, dose 1, dependent
    MedDRA: Vision blurred — Feeling: Good
    Free text: Blurry vision
    MedDRA releases: 2024-11 · check-in free text available
  4. 2022-02-11
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Ocular discomfort — Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activities
    Free text: Eyes feel funny
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-02-12
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2022-02-13
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-02-14
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-02-17
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  9. 2022-02-24
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  10. 2022-03-03
    Dose 2 — Pfizer-BioNTech
  11. 2022-03-04
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  12. 2022-03-05
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  13. 2022-03-06
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  14. 2022-03-07
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  15. 2022-03-08
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  16. 2022-03-09
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  17. 2022-03-10
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  18. 2022-03-17
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  19. 2022-03-26
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  20. 2022-04-01
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  21. 2022-04-07
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  22. 2022-04-14
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  23. 2022-06-02
  24. 2022-09-01
  25. 2023-03-06

Vaccinations

DoseDateManufacturerCo-administered
12022-02-10Pfizer-BioNTech No
22022-03-03Pfizer-BioNTech No

Free text

Release 11 — day 0, dose 1, dependent

2022-02-10

Systemic reaction (other): Blurry vision

Release 11 — days 1–6 daily, dose 1, dependent

2022-02-11

Systemic reaction (other): Eyes feel funny

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROOcular discomfort · · ✓
SROVision blurred · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release